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Edited by Lukas HuberAbstract This study focused on identifying the signalling medi-
ating the eﬀect of magnolol on corticosterone production. Mag-
nolol-induced corticosterone production was completely inhibited
by mitogen-activated protein kinase kinase (MEK)-inhibitor
PD98059, tyrosine kinase (TK)-inhibitor genistein or Janus
tyrosine kinase 2 (JAK2)-inhibitor AG490, suggesting that
extracellular signal-regulated kinase (ERK) and JAK2 are both
involved in this signaling cascade. Further, magnolol induced the
transient phosphorylation of MEK, ERK, cAMP response-ele-
ment binding protein (CREB) and the expression of 32 and
30 kDa steroidogenic acute regulatory protein (StAR) in a
time-dependent manner. Inhibition of TK or JAK2 activities
blocked magnolol-induced phosphorylation of MEK and ERK,
again supporting the upstream role of JAK2. The activation of
JAK2 or MEK apparently mediated the magnolol-induced phos-
phorylation of CREB and the upregulation of StAR. These ﬁnd-
ings demonstrate a novel pathway for magnolol to induce the
expression of StAR, which regulates the rate-limiting step in
sterodiogenesis.
 2005 Federation of European Biochemical Societies Published
by Elsevier B.V. All rights reserved.
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Steroidogensis1. Introduction
Recent studies indicate that signaling pathways other than
protein kinase A (PKA) and protein kinase C, including
extracellular signal related-regulated kinase (ERK) and tyrosine
kinase (TK) pathways regulate steroidogensis in adrenal Y1 and
bovine adrenal glomerulosa cells [1–3]. In rat Leydig cells, inhi-
bition of ERK activation suppresses human chorionic gonado-
tropin-induced steroidogenesis by controlling the synthesis of
steroidogenic acute regulatory protein (StAR) protein [4]. In
addition, luteinizing hormone and follicle stimulating hormone
also induce ERK1/2 phosphorylation and stimulate progester-
one production in rat ovarian granulose cells [5]. Genistein
inhibits angiotensin II (Ang II)-induced calcium inﬂux and aldo-
sterone production in bovine glomerulosa cells and 3b-hydroxy-
steroid dehydrogenase activity in H295R cells [6,7]. Moreover,Abbreviations: Ang II, Angiotensin II; CREB, cAMP response-
element binding protein; ERK, extracellular signal related-regulated
kinase; HSL, hormone-sensitive lipase; JAK2, Janus tyrosine kinase 2;
MEK, mitogen-activated protein kinase kinase; PBS, phosphate-
buﬀered saline; PKA, protein kinase A; SF-1, steroidogenic factor 1;
StAR, steroidogenic acute regulatory protein; TK, tyrosine kinase
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doi:10.1016/j.febslet.2005.06.068activation of TKbyﬁbroblast growth factor, a receptor TKago-
nist, rapidly increases the phosphorylation ofmitogen-activated
protein kinase kinase (MEK) and ERK isoforms in Y1 adrenal
tumor cells [8]. Recently, prolactin was found to stimulate por-
cine adrenal cortisol production via a TK-dependent process
[9]. More speciﬁcally, Src kinase inhibitor PP2 prevents Ang
II-stimulated aldosterone production [7]. Janus tyrosine kinase
2 (JAK2), a member of the family of soluble tyrosine kinases,
is activated by auto- or trans-phosphorylation of speciﬁc tyro-
sine residues [10]. Inhibition of JAK2 activity by AG490 blocks
Ang II-induced StAR promoter activity and steroid production
[11]. In 3T3-422A cells, JAK signaling can lead to the recruit-
ment of other SH2 domain-containing proteins to JAK2, such
as the Shc adaptor protein, leading to the activation of the
Ras-ERK signaling pathway [12].
In a series of magnolol-related studies, we found that magno-
lol also induces lipolysis in lipid-laden RAW264.7 macrophages
[13] and sterol ester-loaded 3T3-L1 preadipocytes, and the sig-
naling pathway of the latter event involves ERK [14]. However,
whether the same signaling pathway accounts for magnolol-in-
duced steroidogenesis in adrenal cells has not yet been eluci-
dated. In this study, we examined the involvement of ERK in
magnolol-activated signaling pathways in adrenal cells.2. Materials and Methods
2.1. Cell culture
Adult female Wistar rats (8–12 weeks of age) were purchased
from the facility for Research Animal of the National Taiwan
University. The maintenance and use of the animals were in accor-
dance with the ‘‘Guide for the Care and Use of Laboratory Ani-
mals’’ published by the US National Institute of Health (NIH
publication No. 85-23, revised 1985). The animals were anesthetized
with 7% chloral hydrate (6 ml/kg) by intraperitoneal injection, and
adrenocortical cells were prepared by enzymatic dispersion with type
II collagenase (Sigma) as described previously [15]. Cells were main-
tained in 1:1 v/v mixture of Hams F12 medium and Dulbeccos
modiﬁed Eagles medium (Gibco, Rockville, MD), supplemented
with 25 mM HEPES, 5% horse serum (Gibco), 2.5% fetal bovine
serum (Gibco), and 1% penicillin and streptomycin in 24-well plates
or 35-mm culture dishes for 3 days at 37 C in a 95% air and 5%
CO2 humidiﬁed atmosphere.2.2. Drug treatment
Magnolol, isolated from Magnolia oﬃcialis with a purity of over
99%, was purchased from the Pharmaceutical Industry Technology
and Development Center (Taiwan). The MEK inhibitor, PD98059,
and selective JAK2 inhibitor, AG490, were purchased from Calbio-
chem (La Jolla, CA). TK inhibitor genistein was purchased from
Sigma Chemical Co. (St. Louis, MO). Proteaosome inhibitor MG
132 was obtained from Tocris Cookson Ltd. (Avonmounth,
UK). The inhibitors were added 30 min prior to the addition of
magnolol.blished by Elsevier B.V. All rights reserved.
Fig. 1. Time- and dose-dependent response of magnolol on adrenal
steroidogenesis. Adrenal cells were treated with 0.1% DMSO (vehicle
control) or diﬀerent concentrations of magnolol (10, 20, 30 lM) for 3,
6, 12 and 24 h. The culture supernatants were assayed for corticoste-
rone. Results given are from a representative of three separate
experiments performed in triplicate.
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Cells were treated with DMSO (vehicle control) or magnolol at dif-
ferent concentrations for 6 h, washed with phosphate-buﬀered saline
(PBS) and incubated with propidium iodide (50 lg/ml in serum-free
medium) for 1 h in a CO2 incubator. After a brief wash with PBS, live
cells were ﬁxed in 10% formalin for 5 min, washed with PBS and
mounted in ﬂuorescence mounting medium. For nuclear staining, cells
were ﬁxed in 5% formalin and 0.5% Triton X-100 for 5 min at room
temperature, washed with PBS and stained with DAPI (4 0,6-diami-
dino-2-phenylindole, Sigma) solution (1 lg/ml DAPI in 0.9% NaCl)
for 15 min. The apoptotic cells were identiﬁed by the presence of
chromatin condensation or apoptotic body formation. All experiments
were performed in triplicate and more than one hundred cells were
examined per dish.
2.4. Corticosterone radioimmunoassay
After drug treatments, 5 ll of the culture medium was diluted
(1:20) with the assay buﬀer (0.05 M Tris–HCl, pH 8.0, containing
0.1 M NaCl, 0.1% NaN3, and 0.1% of bovine serum albumin) and
incubated with 500 ll of 1:10 diluted rabbit anti-corticosterone anti-
body (Sigma). After 20 min at 37 C, 100 ll of 3H-corticosterone
(10000 cpm in assay buﬀer) (Amersham Bioscience, UK) was added
to the mixture and incubated for 1 h at 37 C and then 1 h at 4 C.
The free hormones were adsorbed on 200 ll of dextran-coated char-
coal (0.5% dextran and 1.25% charcoal) in assay buﬀer for 10 min
and the bound hormones separated by centrifugation at
13000 rpm for 10 min. The supernatant (about 0.7 ml) was
transferred to a counting vial containing 3 ml of counting solution
(Ecoscient H) before counting in a b-counter (LS600IC, Beckman,
Fullerton, CA). A standard curve was established using corticoste-
rone standard (Sigma).
2.5. Western blot analysis
After various treatments, cells in 35 mm dishes were washed with
PBS, collected in 50 ll lysis buﬀer (0.15% Triton-X 100, 2 mM
MgCl2, 25 mM HEPES, 60 mM PIPES and 1 mM EDTA, 1 mM
phenylmethylsulfonyl ﬂuoride, 1 lg/ml aprotronin, 1 lg/ml pepstatin
A and 1 lg/ml leupeptin, pH 6.9) and sonicated for 20 cycles of
10-s pulses. Protein concentrations were determined using a protein
assay kit (BioRad Life Sciences, Hercules, CA), and samples stored
at 20 C until further analysis. Cell lysates (50 lg of protein/lane)
were electrophoresed on a 10% sodium dodecyl sulfate polyacryl-
amide gel and the proteins were transferred to nitrocellulose paper
as described by Fritz et al. [16]. Membrane strips were blocked for
1 h at room temperature with 5% non-fat milk in Tris-buﬀered saline
(TBS; 150 mM NaCl, 50 mM Tris Base, pH 8.2) containing 0.1%
Tween 20, then incubated overnight at 4 C with one of the following
antibodies including mouse anti-phosphorylated ERK (Santa Crutz
Biotechnology, Santa Crutz, CA), rabbit anti-phosphorylated
MEK1/2, rabbit anti- phosphorylated CREB (Cell Signaling Technol-
ogy, Beverly, MA), rabbit anti-StAR antibodies (a kind gift from Dr.
Strauss, J. F., III) or mouse anti-b-actin antibodies (Sigma). Immu-
noblot analyses were performed using alkaline phosphatase-conju-
gated goat anti-rabbit or anti-mouse secondary antibodies (1:7500
dilution, Promega Corp., Madison, WI) and bound antibody visual-
ized using a substrate solution (3.3 mg/ml nitro blue tetrazolium and
1.65 mg/ml 5-bromo-4-chloro-3-indolyl phosphate in 100 mM NaCl,
5 mM MgCl2, 100 mM Tris base, pH 9.5). Some membrane strips
were treated with the stripping buﬀer (1% sodium dodecyl sulfate
in 25 mM glycine, pH 2) for 30 min and reprobed for b-actin by
reacting with mouse monoclonal anti-b-actin, horseradish peroxi-
dase-conjugated sheep anti-mouse IgG (1:7500 dilution, Santa Crutz)
and Western Blotting Luminol Reagent (Santa Crutz). The density of
the bands on the nitrocellulose membrane was quantiﬁed by densi-
tometry using Gel pro 3.1 (Media Cybernetics, Silver Spring, MD).
The density of the band in the control sample was deﬁned as 100%
and the densities of the band in the test sample expressed as a per-
centage of this value.
2.6. Statistical analysis
All experiments were performed at least three times, and the values
are expressed as mean ± S.D. Statistical diﬀerences between treatments
and the control were determined by Students t test procedure. P < 0.05
was considered a statistically signiﬁcant diﬀerence.3. Results
3.1. Involvement of ERK in magnolol-induced steroidogenesis
Magnolol (10–30 lM) signiﬁcantly induced the corticoste-
rone secretion at 3 h of treatment, and this eﬀect was main-
tained for up to 24 h (Fig. 1). Only few propidium iodide-
positive necrotic and apoptotic cells were detected in DMSO
groups, and the percentages of necrotic and apoptotic cells
in 30 lM-treated groups showed no signiﬁcant diﬀerence when
compared with the DMSO groups (data not shown). Higher
concentrations of magnolol (P 40 lM) increased the percent-
ages of both necrotic and apoptotic cells. To obtain evidence
for the activation of ERK by magnolol, we assessed the phos-
phorylation levels of MEK and ERK. Treatment with magno-
lol resulted in a transient phosphorylation of MEK1/2 and
ERK1/2 in a time-dependent manner. The protein levels of
the phosphorylated MEK, ERK1 and ERK2 increased to
2.7-, 1.7- and 1.6-fold, respectively, at 5 min after magnolol
treatment (Fig. 2A).We further tested the eﬀect of MEK inhib-
itor on magnolol-induced steroidogenesis and ERK phosphor-
ylation. Pretreatment with 30 lM of PD98059 resulted in a
dose-dependent inhibition of magnolol-induced corticosterone
production (Fig. 3A) and also signiﬁcantly blocked magnolol-
induced phosphorylation of ERK 1 and ERK2 (Fig. 2B). An-
other MEK inhibitor U0126 similarly inhibited magnolol-in-
duced steroidogenesis (data not shown). These data suggest
that the MEK–ERK signaling pathway is required for magno-
lol-induced steroidogenesis.
3.2. Involvement of JAK2 in magnolol-induced steroidogenesis
and biochemical evidence for the link between JAK2 and
ERK pathway
To assess the potential role of TK in the stimulatory eﬀect of
magnolol on steroidogenesis, the action of the TK inhibitor
Fig. 3. Eﬀects of MEK- , TK- and JAK2-inhibitors on magnolol-
induced steroidogenesis. (A) Adrenal cells were treated with 0.1%
DMSO, 30 lM magnolol (Mag), or magnolol plus diﬀerent concen-
trations of PD98059 for 6 h. (B) Cells were treated with DMSO,
genistein (30 lM) or magnolol (30 lM) plus genesitein for 6 h. (C)
Cells were treated with DMSO, magnolol (30 lM) or magnolol plus
diﬀerent concentrations of AG490 for 6 h. The culture supernatants
were assayed for corticosterone. \P < 0.05; \\P < 0.01 compared to the
Mag group.
Fig. 2. Involvement of TK and JAK2 in magnolol-induced phosphor-
ylation of MEK and ERK. (A) Adrenal cells were incubated with
30 lM magnolol for diﬀerent intervals. Cell homogenates were
analyzed for phosphorylated MEK1/2, phosphorylated ERK1/2 or
b-actin (loading control) by immunoblotting. (B) Adrenal cells were
treated for 30 min with diﬀerent inhibitors (30 lM PD98059, 30 lM
genistein, 50 lM AG490) prior to the incubation with 0.1% DMSO or
30 lM magnolol (Mag) for 5 min. The cell homogenates were
immunoblotted for phosphorylated MEK1/2 or phosphorylated
ERK1/2. b-Actin served as loading control. Results are from a
representative experiment.
Y.-C. Chen et al. / FEBS Letters 579 (2005) 4337–4343 4339genistein on this pathway was examined. Genistein (30 lM)
was found to signiﬁcantly abolish magnolol-induced steroido-
genesis (Fig. 3B). Moreover, genistein inhibited magnolol-in-
duced MEK and ERK phosphorylation (Fig. 2B). These
data indicate that TK plays a role in magnolol-induced
MEK and ERK activation and in the subsequent stimulation
of steroidogenesis. In order to clarify the involvement of Src
kinase, we investigated the eﬀect of the Src kinase inhibitor
PP1 on magnolol action. Magnolol transiently increased the
protein levels of phosphorylated Src kinase, however, cotreat-
ment with PP1 did not prevent magnolol-induced steroidogen-
esis (data not shown). Thus, activation of the Src kinase by
magnolol is unlikely to contribute to the increased steroid pro-
duction. We then examined the role of another possible candi-
date of nonreceptor TK, JAK2. The JAK2 inhibitor AG490
signiﬁcantly inhibited magnolol-induced corticosterone pro-
duction (Fig. 3C). The presence of the link between JAK2
and ERK pathway was supported by the observation that
AG490 inhibited magnolol-induced phosphorylation of
MEK and ERK (Fig. 2B). These data provided evidence that
JAK2 is involved in the magnolol-induced steroidogensis and
acts as the upstream regulator of the MEK–ERK pathway.
3.3. Involvement of CREB and StAR in magnolol-induced
steroidogenesis
A transient increase on the phosphorylation of CREB with
time was noted after magnolol treatment (Fig. 4A). We next
examined the roles of TK, JAK2 and ERK in magnolol-in-
duced CREB phosphorylation. Pretreatment with PD98059,
Fig. 4. Eﬀects of MEK-, TK- and JAK2-inhibitors on magnolol-
induced CREB phosphorylation. (A) Adrenal cells were treated with
DMSO or 30 lMmagnolol for diﬀerent intervals, followed by analyses
of cell homogenates for phosphorylated CREB or b-actin. (B)
PD98059 (30 lM), genistein (30 lM) or AG490 (50 lM) were added
30 min prior to the addition of magnolol (30 lM, 10 min). Results are
from a representative experiment performed in triplicate with b-actin
as loading control.
Fig. 5. A time-course study of magnolol-induced expression of 32 and
30 kDa StAR proteins. (A) Adrenal cells were treated with DMSO or
30 lM magnolol for diﬀerent intervals, followed by analyses of cell
homogenates for StAR protein. (B) Densitometric scans of triplicate
blots for 30 kDa StAR protein levels from three independent exper-
iments. \P < 0.05, \\P < 0.01 compared to the 0-min group. (C)
PD98059 (30 lM), genistein (30 lM) or AG490 (50 lM) were added
30 min prior to the addition of magnolol (30 lM, 60 min). Cell
homogenates were analyzed with rabbit anti-StAR antibodies or
mouse anti-b-actin antibody by immunoblotting. Results are from a
representative experiment.
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induced by magnolol (Fig. 4B). Thus, magnolol increases
CREB phosphorylation via the JAK2–MEK–ERK pathway
in adrenal cells. Eﬀorts were then made to identify the possible
downstream targets of the CREB phosphorylation. The rabbit
anti-StAR antibody used in this study detects a major 30 kDa
band and a minor 32 kDa band only in overloaded samples
from DMSO-treated cells (Fig. 5A). Magnolol increased the
protein levels of both 32 and 30 kDa StAR proteins in a
time-dependent manner (Fig. 5B). The increase of the
30 kDa StAR was detected as early as 15 min after magnolol
stimulation and was sustained for a period of at least 6 h (data
not shown). In order to examine whether proteasomes were in-
volved in the initial increase of 30 kDa StAR, the eﬀect of a
nonclassical proteasome inhibitor MG132 was examined.
Upon pretreatment with MG132, no signiﬁcant eﬀects on the
protein levels of 32 and 30 kDa were observed, as compared
with those in the magnolol-treated group (data not shown).
To examine whether the activation of TK, JAK2 and ERK
regulate the expression of StAR proteins, the eﬀects of speciﬁc
inhibitors were investigated. Magnolol-induced 30 kDa StAR
protein expression was slightly decreased by the pretreatment
with PD98059, genistein or AG490 after short-term treatment
(15 min) (not shown) and more pronounced after long-term
treatment (60 min) (Fig. 5C). In conclusion, these results dem-
onstrate that the magnolol-induced increase in 30 kDa StAR
protein expression is mediated by the JAK2–MEK–ERK–
CREB pathway.4. Discussion
Recent studies have shown that nonreceptor TK, including
JAK2 and Src kinase, are important for steroidogensis
[7,11,17,18]. In this study, pretreatment with a Src kinaseinhibitor PP1 had no eﬀect on magnolol-induced steroidogen-
esis, thus excluding the involvement of Src kinase in this event.
We further demonstrated that inhibition of TK with genistein
or selective inhibition of JAK2 with AG490 blocked magnolol-
induced corticosterone production. Moreover, AG490 pre-
treatment decreased magnolol-induced phosphorylation of
MEK and ERK and blocked magnolol-induced StAR protein
levels. Thus, JAK2 is a major upstream activator of MEK–
ERK pathway.
Several lines of evidence support the role of ERK1/2 in adre-
nal steroidogenesis [19]. In other cell types, MEK–ERK acts as
an integrator of mitogen signals originating from receptor TK
and G-protein coupled receptors. Previously, ERK1/2 activa-
tion has been implicated in both positive and negative regula-
tion of steroidogenesis, depending on the agonists used or the
cell type studied [3,5,20–23]. In our study, magnolol rapidly
stimulated the phosphorylation of MEK and ERK1/2. More-
over, PD98059 completely inhibited magnolol-stimulated ste-
roidogenesis and ERK1/2 phosphorylation, suggesting that
ERK1/2 activation is positively correlated with the magno-
lol-induced steroidogenesis.
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hormone sensitive lipase (HSL), steroidogenic factor 1 (SF-
1), CREB and StAR proteins [3,4,24,25]. Several investi-
gations have shown that the phosphorylation of CREB is
critical for steroidogenesis and StAR protein expression
[26–28]. In the classical cAMP-PKA signaling pathway, acti-
vated PKA phosphorylates CREB on Ser133, which subse-
quently increases the association with the CREB binding
protein co-activator and results in histone modiﬁcation and
increased transcription [29]. In this study, we observed the
transient phosphorylation of CREB by magnolol. We then
investigated the possibility for magnolol-induced activated
JAK and ERK to phosphorylate CREB. The data suggested
that JAK and ERK were responsible for magnolol-induced
CREB phosphorylation, since inhibition of TK, JAK2 or
MEK blocked CREB phosphorylation stimulated by magno-
lol, and the time course of ERK phosphorylation matched
temporally with that for CREB phosphorylation. Thus, it
is possible that magnolol-induced CREB phosphorylation
may contribute to steroid synthesis by stimulation of StAR
pre-protein synthesis via a direct binding of pCREB to the
StAR promoter as observed in Leydig cells [28]. In the neu-
ronal system, Burtons tyrosine kinase, a member of Tec
family of TK, has been shown to phosphorylate CREB pro-
tein in immortalized hippocampal progenitor cells [30].
Although our data demonstrated that activation of JAK2–
MEK–ERK cascade increased CREB phosphorylation, the
possibility that JAK2 might directly phosphorylate CREB
should be considered.
It has been indicated that phosphorylated CREB can syner-
gistically interact with SF-1 in upregulating the expression of
StAR pre-protein in MA-10 mouse Leydig tumor cells and
Y1 adrenal tumor cells [26,31]. SF-1 is shown to be essential
to both basal and hormone-induced regulation of the StAR
gene [32,33]. Gyles et al. [3] have demonstrated that the
ERK-dependent phosphorylation of SF-1 enhances its binding
to the StAR promoter. Therefore, further studies are needed to
determine whether SF-1 is phosphorylated by ERK activation
induced by magnolol.
In response to hormonal stimulation, StAR pre-protein
(37 kDa) is rapidly synthesized in the cytosol, phosphory-
lated by PKA and imported into the mitochondria while it
actively transports cholesterol from the cytoplasmic pool
into the mitochondria [34–36]. The 37 kDa pre-protein is
subsequently cleaved by mitochondrial matrix proteases
and generates 32 and 30 kDa proteins [37,38]. Since the
37 kDa pre-protein and 32 kDa protein have short half-lives
of 5.4 ± 1.1 and 4.4 ± 0.8 min, respectively, they are detected
in small quantities in the basal state. In contrast, the 30 kDa
StAR protein has a longer half-life (4–5 h), and predomi-
nates over the other two forms [37]. Thus, the expression
of 30 kDa StAR protein directly correlates with the steroido-
genic activity in the previous study [37]. Due to the failure
of our anti-StAR antibodies to detect the 37 kDa pre-pro-
tein, we only observed the time-dependent increases of 32
and 30 kDa StAR proteins by magnolol stimulation. The
time-course of magnolol-induced steroid production was
consistent with the expression of 32 and 30 kDa StAR pro-
teins which maintained a high level up to at least 6 h after
magnolol stimulation. In rat adrenal cells, pretreatment with
MG 132 did not prevent the initial rise on the 30 kDa StAR
protein induced by magnolol. In this cell type, the transportof the 37 kDa pre-protein may be too rapid to be degraded
by the proteasome. Tajima et al. [39] showed that pretreat-
ment with MG132 increased the contents of 37 kDa pre-pro-
tein in human granulose cells at 15 min after stimulation
with human chorionic gonadotrophin. Moreover, 32 kDa
protein could only be detected 1–2 h later, and no change
was found in 30 kDa StAR. Although the 30 kDa StAR
could be degraded from the pre-existing 37 kDa pre-protein
in a proteasome-dependent way in the cytosol [38], our
experiment favors the point that the observed increase of
the 30 kDa StAR might derive from the cleavage of newly
synthesized 37 kDa pre-proteins. This is supported by the
observations that both the levels of 32 and 30 kDa proteins
increased simultaneously in the initial phase and the failure
of MG132 to block the initial increase of 32 and 30 kDa
proteins. This hypothesis is supported by the facts that
newly synthesized S35 labelled 32 and 30 kDa StAR proteins
could be detected within 15 min after dibutyryl cAMP stim-
ulation in a pulse-chase time course study in adrenal cells
[37] and that 90–97% of S35-labelled 37 kDa pre-protein
can be degraded into S35-30 and -32 kDa proteins within
15 min after cAMP stimulation [40]. The increased StAR
pre-protein mRNA expression induced by ERK activation
is responsible for steroidogensis [3]. In Y1 mouse adrenal
cells, both PD98059 and U0126 treatment decreased for-
skolin-induced progesterone production and StAR pre-pro-
tein mRNA levels [3,41]. In primary culture of rat ovarian
granulosa cells, MEK inhibitor U0126 also blocked folli-
cle-stimulating hormone-stimulated StAR pre-protein
mRNA [23]. The present study demonstrated that pretreat-
ment of PD98059, genistein or AG490 prevented magno-
lol-induced expression of 30 kDa StAR protein. Our data
are consistent with the involvement of ERK1/2 in the regu-
lation of StAR mRNA expression. Previous studies indicate
that the 37 kDa pre-protein can only be phosphorylated by
PKA [42,43]. The question then arises as to which kinases
are responsible for the phosphorylation of 37 kDa pre-pro-
tein in the PKA-independent magnolol action.
Another contribution for activated ERK in steroidogenesis
may be mediated by manipulating HSL activity. In 3T3-L1
adipocytes, ERK activation phosphorylates HSL and in-
creases the activity of HSL, which in turn stimulates lipoly-
sis [44]. In addition, HSL has recently been proven to be
responsible for the majority of the neutral cholesterol ester
hydrolase activity in the adrenal cells [45]. Cherradi et al.
[24] indicate that activation of ERK stimulates aldosterone
production by increasing HSL activity in adrenal glomerul-
osa cells. Therefore, magnolol-induced ERK activation
may directly phosphorylate and activate the HSL, which in
turn increases steroid production, although this needs to
be examined. Our previous study has shown that the inhibi-
tion of protein synthesis by cycloheximide could only pre-
vent half of the steroid production induced by magnolol
[46]. This indicates that magnolol-induced expression of
30 kDa StAR was not completely responsible for magno-
lol-induced steroidogenesis.
In summary, we propose a novel pathway that contributes to
magnolol-induced adrenal steroidogenesis. Activation of
JAK2–MEK–ERK is required for this process. We further
provide evidence that the CREB phosphorylation and the
expression of 30 kDa StAR proteins are the events subsequent
to ERK activation.
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